key: cord-0703845-0hrmk77p authors: Khan, Md. Mostaured Ali; Khan, Md Nuruzzaman; Mustagir, Md. Golam; Rana, Juwel; Haque, Md. Rajwanul; Rahman, Md. Mosfequr title: COVID-19 infection during pregnancy: A systematic review to summarize possible symptoms, treatments, and pregnancy outcomes date: 2020-04-03 journal: nan DOI: 10.1101/2020.03.31.20049304 sha: 8f6833be2037907eecb0edd1d2b536c583d36444 doc_id: 703845 cord_uid: 0hrmk77p Abstract Background: With the exponential increase in coronavirus disease 2019 (COVID-19) worldwide, an increasing proportion of pregnant women are now infected during their pregnancy. The aims of this systematic review were to summarize the possible symptoms, treatments, and pregnancy outcomes of women infected with COVID-19 during their pregnancy. Methods: Four databases (Medline, Web of Science, Scopus, and CINAHL) were searched on March 25, 2020, using the following keywords: 'COVID-19', 'nCoV-2019', and 'coronavirus'. Articles included if they reported either the symptoms, treatments for the women who had been infected with the COVID-19 during their pregnancy or pregnancy outcomes. The selected articles' results were summarized employing a narrative synthesis approach. Results: A total of nine studies were selected for this study, comprising 101 infected pregnant women. Other than the infected general population, infected pregnant women reported different symptoms; however, fever (66.7%), cough (39.4%), fatigue (15.2%), and breathing difficulties (14.1%) were common. Infected pregnant women were given different treatments than the general infected population. The C-section was a common (83.9%) mode of delivery among infected pregnant women, and a higher proportion of births were preterm births (30.4%) and low birth weight (17.9%). Conclusions: Pregnant infected women had different symptoms, and they were given dissimilar treatments than the general infected population. Healthcare providers may have appropriately informed about these symptoms and treatments. They, therefore, would be able to handle infection during pregnancy effectively, which would reduce common adverse consequences among infected pregnant women. December 2019 at Wuhan, China); a major epidemic threat that the world has ever been faced 1 . Since then, the virus has been spread to the 204 countries or territories and infected around 7 million people; around 33.5 thousand of which are died as of March 31, 2020 2 . Importantly, these rates of infections and deaths have been changing daily because of its higher transmission capacity. Consequently, the witness countries' healthcare systems are now facing problems to treat properly to the infected people; though many of them are critically infected and need comprehensive care (5%) 3, 4 . Essentially these increasing rates are reported when the World Health Organization (WHO) has declared COVID-19 as global pandemic and asked countries to take aggressive measures that are even reflected in countries various initiatives 5, 6 . The roots of transmission of this virus from an infected to non-infected person are contact with infected person's respiratory droplets (coughs or sneezes) 7 , and touching surfaces or objects that were touched by the infected person 7, 8 , and has the capacity to infect 2.28 person in a day 9 . The virus is prevalent in all age clusters irrespective of sex; however, it could cause more adverse consequences, including deaths for the persons who have pre-existing noncommunicable diseases including diabetes, hypertension, chronic respiratory diseases, and cancer 1 . Importantly, majority of the deaths reported worldwide have occurred among people who had history of one or more morbidity, that are often common among the elderly 1,10 . The causes are many; however, major is the poor immunity capacity of the people having one or more morbidity. Women during pregnancy often face several pregnancy related complications and more susceptible to respiratory pathogens that may put them at higher risk of adverse . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . consequences. Getting COVID-19 infected at this stage, therefore, may put them in further risk of occurring adverse pregnancy and newbron outcomes including deaths; however, the estimate is lacking 11 . The Severe Acute Respiratory Syndrome (SARS) that was reported in 2007 and similar to the present COVID-19 was showed devastating consequences if it had occurred during pregnancy 9, 12 . Earlier diagnosis of the COVID-19 infection status, as well as proper treatment, are important to reduce these adverse consequences. Clear understanding of all possible symptoms following infection during pregnancy and proper treatments are important for that. The available studies on the symptoms of COVID-19 are mainly conducted for the general infected people, where fever, cough, fatigue, and shortness of breath were the common symptoms [13] [14] [15] [16] [17] [18] . Importantly, these symptoms are varied for the pregnant women that are reported in the few relevant studies, though not consistent across studies. For instance, Liu et al. 19 identified cough, shortening of breath, and fatigue alongside with fever were the most important symptoms of COVID-19 among pregnant women, whereas cough and fever were reported as vital symptoms of COVID-19 in the Zhu et al. 20 study. The treatments given to the COVID-19 infected pregnant women are also varied. Oxygen support, antiviral therapy, and antibiotic therapy were the treatments had given to the infected pregnant women included in the Liu et al. 21 study. Alternatively, Zhu et al.'s study 20 reported that antibiotic therapy was avoided for all infected pregnant women and had given oxygen support and antiviral therapy. Under these circumstances, summarizing all possible symptoms and treatments are important to assist healthcare personnel; thus, they would able to make evidence-based decision to identify infected women early and provide the most effective treatments. Moreover, knowledge of the possible adverse outcomes would help healthcare personnel to take earlier precautionary measrues. Therefore, this study summarized the symptoms, . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . treatments, and pregnancy outcomes for the women who have been infected with COVID-19 during their pregnancy. A systematic review following the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) consensus statement was conducted 22 . Relevant and available studies related to COVID-19 infection among pregnant women were included. Systematic computerized literature searches of the Medline, Web of Science, Scopus, and Cinahl database were conducted on March 25, 2020. Studies published since the COVID-19 started were included. Searches were conducted on the basis of individual comprehensive search strategy for each database. We developed search strategy consisting of free-text words, words in title/abstract and medical subject headings (MeSH), combined using the Boolean operators (AND, OR). We also searched reference list of the included articles and selected journals websites. Studies were selected based on the inclusion and exclusion criteria outlined below- Studies included if they reported COVID-19 infection among pregnant women and the following: symptoms of the infection, treatment given, and outcome of pregnancy (if the delivery had occurred). Studies published in English language worldwide irrespective of study design were included. . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . Studies excluded if they reported COVID-19 infection among non-pregnant women or general patients and wrote in other languages than English. We also excluded review papers and the studies where the exposure status (COVID-19 among pregnant women) and the symptoms, treatments, and the outcomes were not clearly reported. Two authors (MMAK, and MGM) extracted information by using a pre-designed, trailed, and modified data extraction sheet. The extracted information included: year of publication, study location, study design, study sample size, symptoms reported, treatment given, and the outcome of the pregnancy (if delivery had occurred). The corresponding author solved any disagreement on information extraction. The modified Newcastle-Ottawa scale as part of the data extraction strategy, was used to assess study quality. The information recorded were dichotomous in nature. We, therefore, used narrative synthesis to summaries findings from all the retrieved studies. All symptoms following the COVID-19 infection among pregnant women, the treatments given to them, and the outcomes of their pregnancy were presented in detail along with relevant data if available. A total of 1,817 articles dating from the inception of the COVID-19 were identified, of which 1,706 articles were excluded based on the title, abstract, and relevance of the research questions. One hundred eleven articles were selected for full-text review, of which 103 articles were excluded because study sample were general infected population (95), reported different outcomes (4) and wrote in other languages than English (2). Total of 8 articles were finally selected for this study. . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . The background characteristics of the selected studies are summarized in Table 1 . All included studies were conducted in China following the initiation of the COVID-19 outbreak in December 2019. Five of the eight included studies were followed retrospective cohort study design, two were cross-sectional, and 1 was a case report. Total of 100 women was included in the selected eight articles; their mean age was 30 years, and majority of them were in the third trimester of pregnancy (gestational age 22-41 weeks). Table 2 presents the symptoms reported in the included studies. Where available, the symptoms were reported case basis included in the studies. The fever (65%), cough (38%) were major symptoms following the COVID-19 infection among pregnant women ( Figure 2 ). The other symptoms reported were fatigue (15%), breathing difficulties (14%), and myalgia (6%). Sore throat (5%), diarrhea (4%), poor appetite (3%), headache (2%), and malaise (2%) were also reported among pregnant women following the COVID-19 infection. Two different pregnant women were also reported mulligrubs and cholecystitis, respectively, which were added to the common symptoms. The treatment pattern of the COVID-19 infection among pregnant women during their pregnancy or following delivery are summarized in Table 3 . Of the seven articles included, four articles reported similar treatments; that was oxygen therapy and antibiotic therapy. Antiviral therapy was also used in some cases. Cefoperazone Sodium, Cephalosporins, Quinolones, Macrolides, were the commonly used antibiotics in antibiotic therapy, whereas in antiviral therapy, Lopinavir (400mg), Ritonavir (100mg), Arbidol, and Oseltamavir were commonly used. . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . The maternal and newborn outcomes following the COVID-19 infection during pregnancy are summarized in Table 4 . This study included 100 women, of which the delivery-related information was available for 59 women; 55 had given live-birth, and the remaining four were still pregnant at the time of study conducted. Of all delivery occurred, 85.4% had gone through the C-section, and around 29.1% of the total delivery were premature. Among these reviewed cases, one maternal death and one neonatal death were also reported following the COVID-19 infection. The birth weight of the babies was normal in most cases, though 16.4% of the newborns had low birthweight (LBW). Only one of the included studies repoted evidence of mother to child transmission of the COVID-19 infection after 36 hours of delivery. The world is now experiencing an exponential increase of the COVID-19 infected people; a significant proportion of them are pregnant women. We summarized the symptoms following the COVID-19 infection among pregnant women, and the treatments are commonly given to them and the outcomes of the pregnancy. Total of eight studies included in this review in which 100 infected pregnant women data were analyzed; majority of them were in the third trimester of pregnancy. All the included studies were conducted in China. Symptoms reported by the pregnant women following COVID-19 infection were slightly different from the common symptom of general infected people; however, fever, and cough were common. Oxygen and antibiotic therapy were given as treatments for majority of the infected pregnant women. Of the sample analyzed in the included eight studies, 55 of them given baby following the infection occurred. Around 85.4% of the infected pregnant women had gone through the C-section; around 29.1% of women had given premature birth, and total of 16.4% of these babies was born with LBW. These summary findings are important, as it will enable healthcare personnel for the better management of pregnant women who have been infected . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . with the COVID-19, which potentially reduce adverse consequences for women as well as their babies. Several questions have been aroused on maternal and neonatal safety if women were infected with the COVID-19 during pregnancy. The causes are complications following getting infected and evidence of higher adverse consequences if it has happened with existing morbidity, and these could be added to the usual pregnancy and delivery-related complications. These, may increase the occurrence of adverse maternal health and birth outcomes though estimates are lacking. Importantly, earlier detection of the infection through tests, symptoms, and effective treatments could reduce this risk. As revealed in this study based on available published research, fever, cough, fatigue, breathing difficulties are common symptoms among pregnant women following the COVID-19 infection, these symptoms are also common among the general patients 23,24 . Though majority of the symptoms are almost similar, pregnant infected women had some additional symptoms, including sore throat, myalgia, and poor appetite. Postpartum fever was also highly observed for women following delivery. Therefore, close monitoring of these symptoms could be an effective way of early detection of COVID-19 infection during pregnancy. Previous corona like virus outbreak, such as infection of the SARS during pregnancy, reported malaise, chills, and rigors as common symptoms along with fever, cough, and breathing difficulties 25 . Given no specific treatments or vaccines are discovered yet, the COVID-19 infection during pregnancy would put healthcare providers in additional challenges 23 . This is because of the possible adverse effects of the medicine used on the fetus as well as pregnancy. For instance, there are evidence that medicine such as chloroquine and hydroxychloroquine that are currently recommending for patients with the COVID-19 26 may cause fetal harm 27 and may adversely affect newborn through transferring from mother body by breastmilk 28, 29 . Therefore, precautious are needed in the treatments of infected pregnant women. This study . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . revealed that most infected pregnant women were given symptomatic and supportive treatments considering pregnancy, though anti-inflammatory and antiviral treatments had been used in some cases 30, 31 . Importantly, this study summarized the common given antiviral treatments to the infected pregnant women were oseltamivir, lopinavir (400mg), and ritonavir (100mg); the medicine which are different from usual recommended medicines to treat the COVID-19 in general population 26 . Therefore, healthcare providers may have to be careful about given antiviral treatments to the infected pregnant women. Additionally, oxygen therapy and antibiotic therapy (e.g., cefoperazone sodium) have been used in some cases 31, 32 . Notably, further cautious measures are needed to choose the medicine from previous experience on SARS and its treatments, which is considered similar to COVID-19 infection and there are many similarities on treatments given for these infections. For instance, the oxygen and antiviral therapy (drug includes Ribavirin, Ritonavir, Lopinavir) are used in both SARS and COVID-19 33 . However the corticosteroids was not used to treat COVID-19 though it was used to treat SARS among pregnant women. There is evidence that the use of corticosteroids during pregnancy increase the risk of preterm birth, low birthweight and preeclampsia 34 . Additional important findings of this study were the higher occurrence of adverse maternal newborn outcomes among COVID-19 infected mothers. For instance, as this study reported, around 83% of the infected mothers had birth reported use of C-section; a rate that is significantly higher than the usual WHO's recommendation of 1-5% use of C-section to avoid death and severe morbidity in mother and newborns 35, 36 . Getting COVID-19 infection increases complex viral infection among women in pregnancy; therefore, C-section is recommended to reduce perinatal and neonatal adverse outcomes 37 . We also confirm the evidence of the higher occurrence of preterm birth and LBW among the COVID-19 infected mothers than their counterparts. These associations are unique as the previous round of viral . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . infection such as SARS did not find any evidence of association between infection during pregnancy and occurrence of LBW and preterm birth [38] [39] [40] [41] . Viral infection affects pregnancy and fetal growth by gaining access to the placenta and decidua via hematogenous transmission or the lower reproductive tract that lead to the occurrence of such adverse outcomes 42 . However, effects can vary across cell types and gestational age and can be influenced by changes in the uterine environment and maternal immunity 42 . Therefore, earlier preparedness of the healthcare sectors to handle these adverse consequences would be helpful to reduce further adverse outcomes, including maternal and perinatal mortality. The study has several strengths and limitations. This is the first study of its kind that highlighted the symptoms, the treatments, and the pregnancy outcomes among women who have been infected with the COVID-19. The findings may help physicians to take proper initiatives. We did not set any time and study design restrictions that allowed us to include a higher number of studies. However, the major limitation is generalizability; all studies included in this review were conducted in China. Different treatments may be used to treat COVID-19 during pregnancy in other countries. Moreover, none of the studies included reported quantitative data that restricts us to narrate the selected study's findings rather than given any pool estimates. Nevertheless, this study still important and will make healthcare providers informed about the symptoms, treatments, and possible outcomes if pregnant women have been detected with the COVID-19. This study confirms fever, cough, and breathing difficulties are the major symptoms of COVID-19 infection among pregnant women. These are similar to the symptoms reported for the general infected patients; however, some additional symptoms are postpartum fever and breathing difficulty. The recommended treatments such as chloroquine and . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . hydroxychloroquine for the infected people are not applicable for the pregnant women because of their potential adverse affect on the fetus and newborn, therefore supportive and symptomatic treatment are given to them. The COVID-19 infection during pregnancy also increase risks of several adverse outcomes, including higher rates of C-section delivery, low birth weight, and preterm birth. Healthcare providers may consider these for effective management of COVID-19 infected pregnant women, which would reduce pregnancy-related adverse consequences including maternal and newborn morbidity and mortality . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . . It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the The copyright holder for this preprint . ; a Human Serum Albumin based delivery; b Traditional Chinese medicine was also used; c two patients were treated with a single antibiotic and five patients were given combination therapy . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . 16 articles were assessed for eligibility 8 full-text articles were excluded because of the following reasons - • Different outcomes (4) • Wrong study design (2) • In other language (2) 3 additional articles were identified through checking references in selected articles and selected journals 2917 articles were identified through database searching after duplicates were removed • All articles reported patients perspectives • 4 articles were retrospective study • 2 study were cross-sectional study • 1 study was case report 8 articles were selected for this study 95 articles were excluded due to those were not related to pregnant women or newborns 111 articles were assessed for eligibility . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . Symptoms . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03. 31.20049304 doi: medRxiv preprint COVID-19) Novel Coronavirus (COVID-19) Situation. World Health Organization Q&A: The novel coronavirus outbreak causing COVID-19 COVID-19 Coronavirus Pandemic (Real time database) Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study COVID-19: towards controlling of a pandemic A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China The first 2019 novel coronavirus case in Nepal. The Lancet Infectious diseases First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan First Case of 2019 Novel Coronavirus in the United States The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia. The Lancet Clinical and CT Imaging Features of the COVID-19 Pneumonia: Focus on Pregnant Women and Children Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Pregnancy outcome following first trimester exposure to chloroquine Transfer of drugs and other chemicals into human milk Chloroquine accumulates in breast-milk cells: potential impact in the prophylaxis of postnatal mother-to-child transmission of HIV-1 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Antiviral agents and corticosteroids in the treatment of severe acute respiratory syndrome (SARS) Socio-demographic predictors and average annual rates of caesarean section in Bangladesh between The impact of cesarean delivery on transmission of infectious agents to the neonate Chronic hepatitis B infection and risk of preterm labor: a meta-analysis of observational studies The risk of placental abruption and placenta previa in pregnant women with chronic hepatitis B viral infection: a systematic review and meta-analysis Burden and Risk Factors for Coronavirus Infections in Infants in Rural Nepal Coronavirus-related nosocomial viral respiratory infections in a neonatal and paediatric intensive care unit: a prospective study Risks associated with viral infections during pregnancy Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery Infants Born to Mothers With a New Coronavirus The authors are grateful to the authors the paper included in this review. Liu et al. 19 -Liu et al. 44